Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2021 USD ($)	Sep. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Sep. 30, 2020 USD ($)	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2021 USD ($) segment	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment									2
Segment Reporting Information [Line Items]
Number of reportable segments | segment									2
Net sales	$ 4,701,000	$ 4,160,000	$ 4,294,000	$ 3,953,000	$ 4,262,000	$ 3,737,000	$ 2,764,000	$ 3,588,000	$ 17,108,000	$ 14,351,000	$ 14,884,000
Depreciation and amortization									1,272,000	1,076,000	1,044,000
Segment net earnings (loss)									2,584,000	2,223,000	2,713,000
Amortization of intangible assets									(619,000)	(472,000)	(464,000)
Net earnings (loss)	$ 662,000	$ 438,000	$ 592,000	$ 302,000	$ 568,000	$ 621,000	$ (83,000)	$ 493,000	1,994,000	1,599,000	2,083,000
MedSurg and Neurotechnology
Segment Reporting Information [Line Items]
Net sales									9,538,000	8,345,000	8,475,000
Orthopaedics and Spine
Segment Reporting Information [Line Items]
Net sales									7,570,000	6,006,000	6,409,000
Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization									1,147,000	954,000	945,000
Segment operating income									4,987,000	4,002,000	4,388,000
Operating Segments | MedSurg and Neurotechnology
Segment Reporting Information [Line Items]
Net sales									9,538,000	8,345,000	8,475,000
Depreciation and amortization									518,000	496,000	488,000
Segment net earnings (loss)									2,807,000	2,414,000	2,304,000
Operating Segments | Orthopaedics and Spine
Segment Reporting Information [Line Items]
Net sales									7,570,000	6,006,000	6,409,000
Depreciation and amortization									629,000	458,000	457,000
Segment net earnings (loss)									2,180,000	1,588,000	2,084,000
Corporate
Segment Reporting Information [Line Items]
Depreciation and amortization									125,000	122,000	99,000
Segment Reconciling Items
Segment Reporting Information [Line Items]
Segment operating income									(605,000)	(503,000)	(480,000)
Acquisition and integration-related charges									(585,000)	(242,000)	(275,000)
Amortization of intangible assets									(619,000)	(472,000)	(464,000)
Restructuring-related and other charges									(386,000)	(458,000)	(226,000)
Medical device regulations									(107,000)	(81,000)	(62,000)
Recall-related matters									(103,000)	(17,000)	(192,000)
Regulatory and legal matters									2,000	(6,000)	24,000
Net earnings (loss)									$ 2,584,000	$ 2,223,000	$ 2,713,000